Skip to main content
. 2020 Mar 2;9(1):1731943. doi: 10.1080/2162402X.2020.1731943

Figure 6.

Figure 6.

Immunotherapeutic and chemotherapeutic responses in high- and low-risk patients with LUSC (a) Immunotherapeutic responses to anti-CTLA-4 and -PD-1 treatments in high- and low-risk patients. (b) Differential chemotherapeutic responses in high- and low-risk patients.